US Stock MarketDetailed Quotes
SNOA Sonoma Pharmaceuticals
- 2.8500
- -0.0600-2.06%
Close Nov 22 16:00 ET
- 2.9400
- +0.0900+3.16%
Post 20:01 ET
3.82MMarket Cap-2878P/E (TTM)
3.1380High2.8400Low535.09KVolume2.8900Open2.9100Pre Close1.62MTurnover40.59%Turnover RatioLossP/E (Static)1.34MShares9.374052wk High0.71P/B3.76MFloat Cap2.520052wk Low--Dividend TTM1.32MShs Float72323.1863Historical High--Div YieldTTM10.24%Amplitude2.3180Historical Low3.0260Avg Price1Lot Size
About Sonoma Pharmaceuticals Company
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
Company Profile
SymbolSNOA
Company NameSonoma Pharmaceuticals
Listing DateJan 25, 2007
Issue Price4.95
Founded1999
CEOMs. Amy Trombly
MarketNASDAQ
Employees172
Fiscal Year Ends03-31
Address5445 Conestoga Court,Suite 150
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-800-759-9305
Websitehttp://www.sonomapharma.com
Company Executives
- Name
- Position
- Salary
- Amy Trombly
- Director, President and Chief Executive Officer
- 726.54K
- Jerome J. Dvonch
- Chief Financial Officer and Principal Accounting Officer
- --
- Bruce Thornton
- Executive Vice President, Chief Operating Officer and Corporate Secretary
- 658.67K
- Philippe Weigerstorfer
- Independent Director
- 47.50K
- Dr. Jay Edward Birnbaum
- Independent Director
- 55.00K
- Jerry McLaughlin
- Lead Independent Director
- 65.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
